Pharmacist Case Finding and Intervention for Vascular Prevention Trial

Implementation of Pharmacist Case Finding and Intervention for Vascular Prevention (PRxOACT) Study

Heart disease is a common and serious medical condition which causes nearly one in every three deaths worldwide every year.

The factors which increase people's risk for heart disease are well-known, but there needs to be more support given to people to reduce their risk of heart disease. Pharmacists are front line primary healthcare providers who see patients more frequently than any other healthcare provider and can help people reduce their risk of heart disease.

This research project aims to see whether a pharmacist-led intervention can help people reduce their risk of heart disease. The potential impact of this project is to empower people to understand how to reduce their risk of heart disease and reduce the burden of heart disease on the community.

Inclusion Criteria:

• Adults (18 years or older)

• Clinical diagnosis of at least one of the following conditions:

  • Diabetes,
  • Chronic kidney disease,
  • Chronic inflammatory condition (e.g., rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, gout, systemic lupus erythematosus or psoriasis),
  • Atherosclerotic vascular disease,
  • Hypertension,
  • Obesity (defined as body mass index greater than 30),
  • Current tobacco or vape use

Exclusion Criteria:

• Unwilling to participate/sign consent form;
• Unwilling or unable to participate in regular follow-up visits; or
• Pregnant